Title: New approaches to analysing prescription data and to transfer pharmacoepidemiological and evidence‐based reports to prescribers
Abstract: Pharmacoepidemiology and Drug SafetyVolume 11, Issue 8 p. 721-726 ISPE Commentary New approaches to analysing prescription data and to transfer pharmacoepidemiological and evidence-based reports to prescribers Antonio Addis, Corresponding Author Antonio Addis [email protected] Centre for the Evaluation of Effectiveness of Health Care, Modena, ItalyCentre for the Evaluation of Effectiveness of Health Care, (Ce.V.E.A.S), Viale Muratori 201, 41100 Modena, Italy.Search for more papers by this authorNicola Magrini, Nicola Magrini Centre for the Evaluation of Effectiveness of Health Care, Modena, ItalySearch for more papers by this author Antonio Addis, Corresponding Author Antonio Addis [email protected] Centre for the Evaluation of Effectiveness of Health Care, Modena, ItalyCentre for the Evaluation of Effectiveness of Health Care, (Ce.V.E.A.S), Viale Muratori 201, 41100 Modena, Italy.Search for more papers by this authorNicola Magrini, Nicola Magrini Centre for the Evaluation of Effectiveness of Health Care, Modena, ItalySearch for more papers by this author First published: 27 November 2002 https://doi.org/10.1002/pds.785Citations: 17AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Borst-Eliers E. Availability of pharmaceutical drugs. Lancet 2000; 356: S6. 2 Campbell SM, Cantrill JA, Roberts D. Prescribing indicators for UK general practice: Delphi consultation study. BMJ 2000; 321: 1–5. 3 Bergman U, Sjoqvist F. Measurement of drug utilization in Sweden: methodological and clinical implications. Acta Med Scand 1984; 683: 15–22. 4 Bergman U, Popa C, Tomson Y, Wettermark B, Einarson TR, Aberg H, Sjoqvist F. Drug utilization 90%—a sample method for assessing the quality of drug prescribing. Eur J Clin Pharmacol 1998; 54: 113–118. 5 Resi D, Castelvetri C, Vaccheri A, Monanaro N. The therapeutic course as a measure complementary to defined daily doses when studying exposure to antibacterial agents. Eur J Clin Pharmacol 2001; 57: 177–180. 6 Panei P, Addis A, Brunetti M, Caffari B, Da Cas R, Magrini N, Menna A, Ravaioli F, Tosolini F, Raschetti R. The Italian National Drug Use Monitorino Center. Pharmacoepidemiol Drug Safe 2001; 10: S87. 7 Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Audit and feedback: effects on professional practice and health care outcomes (Cochrane Review). In The Cochrane Library, Issue 2, 2002. Update Software: Oxford. 8 Thomson O'Brien MA, Oxman AD, Davis DA, Haynes RB, Freemantle N, Harvey EL. Educational outreach visits: effects on professional practice and health care outcomes (Cochrane Review). In The Cochrane Library, Issue 2, 2002. Update Software: Oxford. Citing Literature Volume11, Issue8December 2002Pages 721-726 ReferencesRelatedInformation